AMAL has started to pull ahead of AJM.AMAL at $0.31, market values the new company at $404.5m, while AJM at $0.19, market values it at $345.8m. Time to chase KDR next.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market